Monday, October 2, 2023
WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.
Consultant Dermatologist
Walsall Healthcare NHS Trust
& The Royal Wolverhampton NHS Trust
West Midlands, United Kingdom
This educational activity is intended for an international audience of non-US dermatologists and nurses involved in the management of patients with vitiligo.
The goal of this activity is that learners will be better able to enhance their ability to understand unmet needs, diagnose vitiligo and initiate therapy in a timely manner, assess and monitor patients, understand how to use current therapies effectively, and appreciate which novel therapies are on the horizon.
Upon completion of this activity, participants will:
WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.
Consultant Dermatologist
Walsall Healthcare NHS Trust
& The Royal Wolverhampton NHS Trust
West Midlands, United Kingdom
The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 1.0 continuing professional development credits (CPD).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information about your
eligibility to claim credit, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must
complete the activity online during the credit eligibility period that is noted on the title page.
Follow these steps to claim a credit certificate for completing this activity:
We encourage you to complete an Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CPD Released: 6/3/2022
Valid for credit through: 6/3/2023, 11:59 PM EST
processing....
The following cases are modeled on the interactive grand rounds approach. The questions within the activity are designed to test your current knowledge. After each question, you will be able to see whether you answered correctly and read evidence-based information that supports the most appropriate answer choice. The questions are designed to challenge you; you will not be penalized for answering the questions incorrectly. At the end of the activity, there will be a short post-test assessment based on the material presented.
 |
Sam is a 22-year-old Black man who presents to the dermatologist because he is concerned about "white spots" on his arms and legs and around his lips. The spots have been present for a year, and he has had no other symptoms. He also has no other relevant issues in his medical history, and is currently not taking any medications. Further examination by the dermatologist reveals that the spots are depigmented macules and patches on dorsal hands, distal legs, and face; the spots show no surface scale or any other epidermal changes. Sam also mentions that he has been very fatigued lately, and sometimes unable to complete his usual weekly workouts. He is distressed by the lesions on his face, especially since they are very visible.
Based on these clinical findings, the dermatologist confirms the diagnosis of vitiligo, and further assessment is needed to investigate for any other underlying autoimmune disorder.
